Neurological disorders

In this March 11, 2020, photo, Kalianthi Karipidu, 89, poses for a photo at the windows of her home in central Rome. Italy has one of the world’s oldest populations, and the coronavirus outbreak is taking its toll on family relationships. The elderly are sealing themselves off from loved ones or can’t be visited due to nursing home rules or travel restrictions. (AP Photo/Alessandra Tarantino)
1010 WINS Newsroom
March 12, 2020 - 6:20 am
ROME (AP) — Natalina De Santis’ three adult children come to her front door, bringing food to keep her healthy and books to relieve her boredom, but she doesn’t let them in any more. Widowed a few months ago and living alone, the 83-year-old resident of Rome is so afraid of catching the coronavirus...
Read More
FILE - In this Aug. 14, 2018 file photo, a doctor looks at a PET brain scan at the Banner Alzheimers Institute in Phoenix. Two experimental drugs failed to prevent or slow mental decline in a study of people who are virtually destined to develop Alzheimer's disease at a relatively young age because of rare gene flaws. The results announced Monday, Feb. 10, 2020, are another disappointment for the approach that scientists have focused on for many years -- trying to remove a harmful protein that builds up in the brains of people with the disease. (AP Photo/Matt York, File)
1010 WINS Newsroom
February 10, 2020 - 8:04 am
Two experimental drugs failed to prevent or slow mental decline in a study of people who are virtually destined to develop Alzheimer's disease at a relatively young age because they inherited rare gene flaws. The results announced Monday are another disappointment for the approach that scientists...
Read More
1010 WINS Newsroom
February 07, 2020 - 12:37 pm
AMSTERDAM (AP) — A Dutch organization that carries out euthanasia received 3,122 requests last year, a 22% increase from the year before, the Euthanasia Expertise Center said Friday. “Every work day, 13 people say: 'Help me, I can’t go on,'” Steven Pleiter, director of the center formerly known as...
Read More
FILE - This June 11, 2018 file photo shows musician Ozzy Osbourne, left, and his wife Sharon Osbourne at the Metal Hammer Golden God awards in London. The 71-year-old Grammy winner and former vocalist for the metal band Black Sabbath said during an interview on “Good Morning America” that aired Tuesday, Jan. 21, 2020, that he's been diagnosed with Parkinson's disease, a nervous system disorder that affects movement. The diagnosis came after a fall last year. (Photo by Vianney Le Caer/Invision/AP, File)
1010 WINS Newsroom
January 21, 2020 - 12:10 pm
NEW YORK (AP) — Rocker Ozzy Osbourne says that he's been diagnosed with Parkinson's disease, a nervous system disorder that affects movement. The 71-year-old Grammy winner and former vocalist for the metal band Black Sabbath said during an interview on “Good Morning America” that aired Tuesday that...
Read More
A Congressional Gold Medal is presented to amyotrophic lateral sclerosis (ALS) advocate and former National Football League (NFL) player, Steve Gleason, in Statuary Hall on Capitol Hill, Wednesday, Jan. 15, 2020, in Washington. Holding the medal is his wife Michel Gleason. (AP Photo/Manuel Balce Ceneta)
1010 WINS Newsroom
January 15, 2020 - 6:05 pm
WASHINGTON (AP) — Former NFL player Steve Gleason has received the Congressional Gold Medal — the highest civilan honor bestowed by Congress — for his work as an advocate for people with Amyotrophic Lateral Sclerosis, also known as Lou Gehrig's disease. “This award represents the people of the...
Read More
People take the ice bucket challenge during the last "Plunge for Pete" event on what would have been Pete Frates' 35th birthday, at Good Harbor in Gloucester, Mass., Saturday, Dec. 28, 2019. Hundreds of people plunged into the chilly ocean at the Massachusetts beach on Saturday to honor Peter Frates, the former college baseball player whose battle with Lou Gehrig’s disease helped spread the ALS ice bucket challenge. (John Blanding/The Boston Globe via AP)
1010 WINS Newsroom
December 28, 2019 - 8:05 pm
GLOUCESTER, Mass. (AP) — Hundreds of people plunged into the chilly ocean at a Massachusetts beach on Saturday to honor Peter Frates, the former college baseball player whose battle with Lou Gehrig’s disease helped spread the ALS ice bucket challenge. About 1,000 people showed up for the final “...
Read More
In this Nov. 22, 2019, photo, Charles Flagg, who is stricken with Alzheimer's disease, receives the contents of an intravenous bag while participating in a study on the drug Aducanumab at Butler Hospital in Providence, R.I. New results were released on the experimental medicine whose maker claims it can slow the decline of Alzheimer's disease, the most common form of dementia. (AP Photo/Charles Krupa)
1010 WINS Newsroom
December 05, 2019 - 3:20 pm
SAN DIEGO (AP) — A company that claims to have the first drug to slow mental decline from Alzheimer's disease made its case to scientists Thursday but left them sharply divided over whether there’s enough evidence of effectiveness for the medicine to warrant federal approval. Excitement and...
Read More
This undated photo provided by Acadia Pharmaceuticals Inc. shows a bottle of Nuplazid, a drug that was tested for treating psychosis related to dementia. If regulators agree, the drug could become the first treatment specifically for dementia-related psychosis and the first new medicine for Alzheimer's in nearly two decades. Results from a study on the drug were disclosed Wednesday, Dec. 4, 2019, at an Alzheimer's conference in San Diego. (Acadia Pharmaceuticals Inc. via AP)
1010 WINS Newsroom
December 04, 2019 - 8:53 pm
SAN DIEGO (AP) — A drug that curbs delusions in Parkinson's patients did the same for people with Alzheimer's disease and other forms of dementia in a study that was stopped early because the benefit seemed clear. If regulators agree, the drug could become the first treatment specifically for...
Read More
1010 WINS Newsroom
November 12, 2019 - 5:40 pm
SAN FRANCISCO (AP) — Billionaire philanthropists Joan and Sandy Weill announced Tuesday they are donating $106 million to launch a research initiative at three West Coast universities aimed at finding treatments for brain disorders like epilepsy and Alzheimer's disease. The donation to the...
Read More
FILE - In this Aug. 14, 2018 file photo, Dr. William Burke goes over a PET brain scan at Banner Alzheimers Institute in Phoenix. The drug company Biogen Inc. says it will seek federal approval for a medicine to treat early Alzheimer's disease, a landmark step toward finding a treatment that can alter the course of the most common form of dementia. The announcement Tuesday, Oct. 22, 2019, is a surprise because the company earlier this year stopped two studies of the drug, called aducanumab, after partial results suggested it was not working. (AP Photo/Matt York, File)
1010 WINS Newsroom
October 22, 2019 - 6:44 pm
Biogen Inc. said Tuesday it will seek federal approval for a medicine to treat early Alzheimer's disease, a landmark step toward finding a treatment that can alter the course of the most common form of dementia. The announcement was a surprise because the drug company earlier this year stopped two...
Read More

Pages